Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01762358
Other study ID # KhalMUG1
Secondary ID
Status Completed
Phase N/A
First received January 4, 2013
Last updated January 4, 2013
Start date June 2005
Est. completion date October 2011

Study information

Verified date January 2013
Source Medical University of Graz
Contact n/a
Is FDA regulated No
Health authority Austria: Ethikkommission
Study type Interventional

Clinical Trial Summary

The primary hypothesis is that Khalifa's therapy brings additional benefit compared to standard therapy (physiotherapy) for patients with a ruptured anterior cruciate ligament (ACL).


Description:

Mohamed Khalifa, a therapist from Hallein (Austria), has been working since 30 years with a self-developed manual technique for treating injuries of the musculoskeletal system especially of the knee by applying high pressure to the skin in the area of the injury. This pressure is applied in various amplitudes and frequencies.

International top athletes from various disciplines reported a rapid pain relief, and even full recovery, immediately after his one hour treatment.

Prior to the investigators' study, the investigators evaluated one pilot patient with a complete ACL rupture after a soccer game with Magnet-Resonance-Imaging (MRI) and clinical tests. This patient was physically immobile and reported pain especially when stretching and bending the knee. After one hour of treatment from Khalifa the signs of the injury like the stretching / bending inhibition and pain were gone immediately. Three months after the treatment, an evaluation of the knee with MRI showed an end-to-end continuous ACL with homogeneous signal and the clinical tests confirmed the stability of the knee.

With this study the investigators will evaluate the possibility of influencing the healing of a completely ruptured ACL of the knee by one single special local pressure treatment to the skin for 60 min.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- totally ruptured ACL - MRI verified, 4 weeks old as a maximum

- knee function: Any functional inhibition (stretching, bending or load)

- BMI: 18-28

- athletically active

Exclusion Criteria:

- any surgical procedures at the injured knee at any previous time

- any acute surgical indication

- diabetes mellitus and/or high blood pressure

- any permanent drug treatment

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Total Rupture of the Anterior Cruciate Ligament in the Knee

Intervention

Other:
Khalifa's therapy
One hour of Khalifa's therapy which is specially applied pressure to the skin
Physiotherapy
Twelve times standardized Physiotherapy

Locations

Country Name City State
Austria LKH Graz
Austria UKH Graz
Austria LKH Kirchdorf
Austria AKH Linz

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Graz

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Other Confidence Confidence in therapists / doctors were evaluated by questionnaire 24 hours, 3 months No
Primary ACL Morphology Magnet resonance images: end-to-end homogeneous anterior cruciate ligament 3 months after 1st therapy No
Primary Knee function IKDC-Score (International Knee Documentation Comite) clinical / physical examination KT-1000 evaluation 24 hours and 3 months after 1st therapy No
Secondary Life Quality A Visual Analogue Scale was used to evaluate: Pain and Well-being 24 hours, 3 months No